Heinz-Werner Kleemann
Aventis Pharma
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Heinz-Werner Kleemann.
Biochimica et Biophysica Acta | 1990
Werner Kramer; Frank Girbig; Ulrike Gutjahr; Heinz-Werner Kleemann; Irina Leipe; Hansjoerg Urbach; Adalbert Wagner
The interaction of two renin inhibitors, S 86,2033 and S 86,3390, with the uptake system for beta-lactam antibiotics and small peptides in the brush border membrane of enterocytes from rabbit small intestine was investigated using brush border membrane vesicles. Both renin inhibitors inhibited the uptake of the orally active cephalosporin cephalexin into brush border membrane vesicles from rabbit small intestine in a concentration-dependent manner. 1.1 mM of S 86,3390 and 2.5 mM of S 86,2033 led to a half-maximal inhibition of the H(+)-dependent uptake of cephalexin. Both renin inhibitors were stable against peptidases of the brush border membrane. The uptake of cephalexin into brush border membrane vesicles (1 min of incubation) was competitively inhibited by S 86,2033 and S 86,3390 suggesting a direct interaction of these compounds with the intestinal peptide uptake system. The renin inhibitors are transported across the brush border membrane into the intravesicular space as was shown by equilibrium uptake studies dependent upon the medium osmolarity. The uptake of S 86,3390 was stimulated by an inwardly directed H(+)-gradient and occurred with a transient accumulation against a concentration gradient (overshoot phenomenon). The renin inhibitors S 86,2033 and 86,3390 also caused a concentration-dependent inhibition in the extent of photoaffinity labeling of the putative peptide transport protein of apparent Mr 127,000 in the brush border membrane of small intestinal enterocytes. In conclusion, these studies show that renin inhibitors specifically interact with the intestinal uptake system shared by small peptides and beta-lactam antibiotics.
PLOS ONE | 2012
Susanne Miehe; Peter Crause; Thorsten Schmidt; Matthias Löhn; Heinz-Werner Kleemann; Thomas Licher; Werner Dittrich; Hartmut Rütten; Carsten Strübing
TRPC channels are a family of nonselective cation channels that regulate ion homeostasis and intracellular Ca2+ signaling in numerous cell types. Important physiological functions such as vasoregulation, neuronal growth, and pheromone recognition have been assigned to this class of ion channels. Despite their physiological relevance, few selective pharmacological tools are available to study TRPC channel function. We, therefore, screened a selection of pharmacologically active compounds for TRPC modulating activity. We found that the synthetic gestagen norgestimate inhibited diacylglycerol-sensitive TRPC3 and TRPC6 with IC50s of 3–5 µM, while half-maximal inhibition of TRPC5 required significantly higher compound concentrations (>10 µM). Norgestimate blocked TRPC-mediated vasopressin-induced cation currents in A7r5 smooth muscle cells and caused vasorelaxation of isolated rat aorta, indicating that norgestimate could be an interesting tool for the investigation of TRP channel function in native cells and tissues. The steroid hormone progesterone, which is structurally related to norgestimate, also inhibited TRPC channel activity with IC50s ranging from 6 to 18 µM but showed little subtype selectivity. Thus, TRPC channel inhibition by high gestational levels of progesterone may contribute to the physiological decrease of uterine contractility and immunosuppression during pregnancy.
Bioorganic & Medicinal Chemistry | 1997
Holger Heitsch; Reinhard H.A. Becker; Heinz-Werner Kleemann; Adalbert Wagner
The synthesis and the SAR study of imidazo[4,5-b]pyridine biphenyl sulfonylureas and -carbamates as highly potent AT1-selective ANG II receptor antagonists are described. Several members of this new class of antagonists efficiently inhibited the ANG II-induced pressor response in pithed rats after iv and intraduodenal (id) administration.
Journal of Hepatology | 2002
Antonio Di Sario; Emanuele Bendia; G. Svegliati-Baroni; Silvia Taffetani; F. Ridolfi; Ursula Schindler; Heinz-Werner Kleemann; C. Candelaresi; Paola Sterpetti; L. Trozzi; Antonio Benedetti
Results: We demonstrate 1) That both core tumour and non-tumourderived sequences inhibit the global antiviral effects of IFNa on VSV and EMCV replication in Ratl and HuH7 cells and sensitize Ref cells to transformation, in cooperation with ras oncogene. 2) That tumour and nontumour derived cores show, however, a quite distinct pattern of biological effects on IFNa signaling: inhibition of global antiviral effect of IFNa in tumour-derived expressing cells is much less pronounced, compared with non tumour-derived and reference lb cores.Expression of tumour-derived, and not non-tumour-derived nor reference lb cores, induces transactivafion of 0interferon sensitive response element0 (ISRE); tumour-derived core also increases phosphorylation of Statl and Stat 2, compared with nontumour-derived and reference lb proteins.Tumour-derived core show a markedly increased transforming activity in REF cells, in cooperation with ras oncogene, compared with non-tumour-derived and reference lb cores. Conclusion: Our data 1) support a role for HCV core in the resistance to global antiviral effect of IFNa (despite ISRE activation) and cell transformation in REF cells. 2) demonstrate a distinct pattern of biological effects of tumour and non-tumour-derived cores on interferon signaling and cell transformation, correlated with the hypothesis of selection of core mutants in clonaly expanding liver cells. Data obtained with 3 additional tumour and non-tumour-derived core sequences will be discussed.
Journal of Medicinal Chemistry | 2003
Stefan Peukert; Joachim Brendel; Bernard Pirard; Andrea Brüggemann; Peter Below; Heinz-Werner Kleemann; Horst Hemmerle; Wolfgang Schmidt
Hepatology | 2003
Antonio Di Sario; Emanuele Bendia; Silvia Taffetani; Marco Marzioni; C. Candelaresi; Paola Pigini; Ursula Schindler; Heinz-Werner Kleemann; L. Trozzi; Giampiero Macarri; Antonio Benedetti
Archive | 1993
Hans-Jochen Lang; Andreas Weichert; Heinz-Werner Kleemann; Heinrich Dr Englert; Wolfgang Scholz; Udo Albus
Archive | 1994
Jan-Robert Schwark; Hans-Jochen Lang; Heinz-Werner Kleemann; Andreas Weichert; Wolfgang Scholz; Udo Albus
Archive | 1992
Adalbert Wagner; Heinrich Dr Englert; Heinz-Werner Kleemann; Hermann Dr. Gerhards; Bernward Prof. Dr. Schölkens; Reinhard Dr Becker; Wolfgang Dr. Linz; Jean-Claude Caille; Jean-Paul Vevert
Bioorganic & Medicinal Chemistry Letters | 2004
Stefan Peukert; Joachim Brendel; Bernard Pirard; Carsten Strübing; Heinz-Werner Kleemann; Thomas Böhme; Horst Hemmerle